Barish Edil to Survival Rate
This is a "connection" page, showing publications Barish Edil has written about Survival Rate.
Connection Strength
0.513
-
Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma. Clin Cancer Res. 2021 03 01; 27(5):1278-1286.
Score: 0.042
-
Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers. Ann Surg. 2019 12; 270(6):1147-1155.
Score: 0.040
-
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin a3ß1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Gastroenterology. 2020 02; 158(3):679-692.e1.
Score: 0.039
-
Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma. J Surg Oncol. 2018 Apr; 117(5):1073-1083.
Score: 0.035
-
Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma. J Am Coll Surg. 2017 Mar; 224(3):362-372.
Score: 0.032
-
A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer. Ann Surg Oncol. 2014 Nov; 21(12):3931-7.
Score: 0.027
-
Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S725-30.
Score: 0.026
-
Young patients undergoing resection of pancreatic cancer fare better than their older counterparts. J Gastrointest Surg. 2013 Feb; 17(2):339-44.
Score: 0.024
-
Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literature. J Gastrointest Cancer. 2012 Sep; 43(3):431-6.
Score: 0.024
-
Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012 Aug; 16(8):1478-86.
Score: 0.024
-
Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012 Jun; 19(6):1928-35.
Score: 0.023
-
Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg. 2011 Nov; 146(11):1277-84.
Score: 0.023
-
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol. 2011 Nov; 18(12):3493-9.
Score: 0.022
-
Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas. Ann Surg Oncol. 2010 Dec; 17(12):3112-9.
Score: 0.021
-
Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg. 2010 Jul; 14(7):1143-50.
Score: 0.020
-
Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010 Mar; 251(3):470-6.
Score: 0.020
-
Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol. 2010 Jan; 41(1):113-22.
Score: 0.020
-
Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009 Aug; 250(2):282-7.
Score: 0.019
-
Pancreatic resection of isolated metastases from nonpancreatic primary cancers. Ann Surg Oncol. 2008 Nov; 15(11):3199-206.
Score: 0.018
-
Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg. 2005 Apr; 79(4):1110-5; discussion 1110-5.
Score: 0.014